OncoLife
The computed 12-month bankruptcy probability of OncoLife is 3.8% (moderate). The 2024 annual accounts show equity of €8k and a net result of €6k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €8k |
| Net result | €6k |
| Active | 5 yrs |
| Locations | 2 |
Mixed profile: strong on profitability, weaker on solvency.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €33k |
| Net profit | €6k |
| Cash flow | €28k |
| Staff costs | €2k |
| Income taxes | €3k |
| Dividends | €231k |
| Total assets | €257k |
| Equity | €8k |
| Debt | €249k |
| of which ≤ 1y | €221k |
| of which > 1y | €28k |
| Working capital | €-36k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.84 |
| Quick ratio | 0.84 |
| Working capital ratio | -14.0% |
| Solvency | 3.0% |
| Debt / equity | 32.42 |
| Long-term debt ratio | 3.59 |
| Interest coverage | 17.70 |
| Gross margin | - |
| Net margin | - |
| ROA | 2.4% |
| ROE | 80.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €257k |
| Fixed assets | 21/28 | €71k |
| Tangible fixed assets | 22/27 | €71k |
| Current assets | 29/58 | €186k |
| Amounts receivable within one year | 40/41 | €17k |
| Cash & bank | 54/58 | €111k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €257k |
| Equity | 10/15 | €8k |
| Contributions / capital | 10/11 | €2k |
| Accumulated profits (losses) | 14 | €6k |
| Amounts payable | 17/49 | €249k |
| Amounts payable after one year | 17 | €28k |
| Amounts payable within one year | 42/48 | €221k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €36k |
| Operating result | 9901 | €11k |
| Financial income | 75 | €21 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €9k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €6k |
| Result to be appropriated | 9905 | €6k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 09-11-2020 |
| Status | Active |
| Postal code | 3090 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21002A0254/00A000 | Brussels | 3.4 ha | 1 · 1.6 ha | 35.9 m · 8 fl. |
| 23062B0130/00W004 | Flanders | 2,305 m² | 1 · 220 m² | 10.7 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
24-02-2025 Change in the board of directors
Technical details
{
"events": [],
"notary": {
"name": "No\u00E9mi EDRICH",
"firm_city": null,
"firm_name": null,
"office_city": "WATERLOO",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-24",
"filing_date": "2025-02-17",
"act_kind_objet": "BUITENGEWONE VERGADERING."
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-01-20",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0757.898.612",
"name_full": "ONCOLIFE",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Ondernemingsrechtbank Brussel",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}07-02-2025 Registered office moved from BRUXELLES to Overijse
- 1000 BRUXELLES, rue de la Senne 57B → 3090 Overijse, Heiberg 1
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "3090 Overijse, Heiberg 1",
"city": "Overijse",
"region": "vlaams_gewest",
"street": "Heiberg",
"country": "BE",
"postcode": "3090",
"box_number": null,
"street_number": "1",
"locality_suffix": null
},
"old_address": {
"raw": "1000 BRUXELLES, rue de la Senne 57B",
"city": "BRUXELLES",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Rue de la Senne",
"country": "BE",
"postcode": "1000",
"box_number": null,
"street_number": "57B",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "No\u00E9mi EDRICH",
"firm_city": null,
"firm_name": null,
"office_city": "WATERLOO",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2025-01-31",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"date": "2025-01-20",
"unanimous": null
},
"subject_company": {
"kbo": "0757.898.612",
"name_full": "ONCOLIFE",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen h bij het Belgisch Staatsbla lad",
"Annexes du M"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | OncoLife |